Phase II Study of Pembrolizumab in Combination with Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma

Project: Research project

Description

Phase II Study of Pembrolizumab in Combination with Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma
StatusActive
Effective start/end date12/1/1711/30/22

Funding

  • BIG TEN CANCER RESEARCH CONSORTIUM